MedTrace Logo

Identification of Biomarkers in Ischemic Stroke - Clinical Trial

NCT04253275 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2024-03-04

No results posted yet for this study

Summary

The objective of the study is to determine RNA blood biomarker based on 9 genes already identified in experimental studies, whose expression would be significantly increased in patient with ischemic stroke compared to controls.

Conditions

  • Stroke, Ischemic
  • Stroke Hemorrhagic

Interventions

GENETIC

blood samples

Blood samples will be taken at inclusion, 12h, 24h, 48h, 7d, 3m and 1y for patients ; at inclusion, 3m and 1y for controls. Microvesicles samples will be taken at inclusion, 7d and 3M ; at inclusion and 3M for controls.

DIAGNOSTIC_TEST

MRI without injection

MRI at inclusion for controls

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Principal Investigators

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-24
Primary Completion
2024-02-06
Completion
2024-02-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04253275 on ClinicalTrials.gov